---
title: PSI vs Sharp Services
slug_a: appian
slug_b: sharpservices
site: cro
review_signal_gate: closed
canonical_path: /compare/appian/sharpservices
---

# PSI vs Sharp Services

Side-by-side profile data from each company listing on this directory.

## PSI

- Profile: [/companies/appian](/companies/appian)

PSI — PSI runs full-service Phase 2 and 3 clinical trials with a stated focus on on-time enrollment and over 90% repeat and referral business. Key therapeutic areas include oncology, GI, hematology, cell and gene therapy, neurology, and infectious diseases.

Services: 3. Modalities: 3. Indications: 9. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in indications (9).

### Services

- Phase II Clinical Trials
- Phase III Clinical Trials
- Clinical Operations

### Modalities

- Cell Therapy
- Gene Therapy
- Radiopharmaceutical

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic
- Cardiovascular
- Infectious Disease
- Respiratory
- Gastroenterology
- Nephrology

### Phases

- Phase II
- Phase III

### Sourcing models

- Full-Service Outsourcing (FSO)

## Sharp Services

- Profile: [/companies/sharpservices](/companies/sharpservices)

Sharp Services — Specialist CDMO offering sterile injectable manufacturing with 100% isolator-based fills, clinical trial services, and commercial packaging for autoinjectors and pre-filled syringes. Operates a network of GMP facilities across the US, UK, and EU.

Services: 0. Modalities: 1. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in modalities (1).

### Services

- Data not yet provided.

### Modalities

- Gene Therapy

### Indications

- Data not yet provided.

### Phases

- Data not yet provided.

### Sourcing models

- Data not yet provided.